Cochrane Abstracts
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticholinergic Bronchodilators Versus Beta2‐sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Systemic_treatments_for_eczema:_a_network_meta‐analysis_New. Accessed 19 April 2024.
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Systemic_treatments_for_eczema:_a_network_meta‐analysis_New. Accessed April 19, 2024.
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Systemic_treatments_for_eczema:_a_network_meta‐analysis_New
Anticholinergic Bronchodilators Versus Beta2‐sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Systemic_treatments_for_eczema:_a_network_meta‐analysis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
ID - 439696
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Systemic_treatments_for_eczema:_a_network_meta‐analysis_New
DB - Evidence Central
DP - Unbound Medicine
ER -
